GuideTechnology readiness

TRL for medical devices in India: what each level looks like, from bench prototype to CDSCO licence

TRL for medical devices explained for Indian startups and researchers: what each level means, the evidence it needs and where CDSCO test licences fit.

By Dr. Abhay Tharmatt, Research Scientist, R&D, Zernyx Innovations 6 min read

Part of the guide TRL levels explained: what TRL 1 to 9 really mean, and how to place your technology

Short answer

For a medical device, the TRL climbs from a proven principle on the bench (TRL 3) to a lab prototype tested against key requirements (TRL 4), a prototype tested in conditions close to clinical use such as simulated use or animal studies (TRL 5 and 6), a device tested in people under a CDSCO-approved clinical investigation (TRL 7), a device with a manufacturing licence made under a quality system (TRL 8) and a device in routine clinical use (TRL 9). Indian funders such as BIRAC publish device-specific definitions, so use their wording when you apply.

Medical device teams often say their device is "at TRL 6" because the prototype works. A grant reviewer or investor will then ask: tested where, against which standard, and with what regulatory step done? For devices, readiness is not just engineering. It is engineering plus safety evidence plus regulation, and the three have to line up.

This guide maps the nine technology readiness levels onto the real milestones a medical device passes in India, including the CDSCO steps under the Medical Devices Rules, 2017. It is written for researchers, clinicians and startups preparing for a BIRAC or other grant, an investor round or an industry partner.

Why device TRL is different

The general TRL scale was built for engineered systems. A device adds two layers:

  • Biological safety. A material that is strong and cheap may still be unsafe in contact with tissue or blood. Safety testing has to happen before human use.
  • Regulation. In India, the Medical Devices Rules, 2017 decide when you need a test licence, when you need permission for a clinical investigation and who grants the manufacturing licence. Those steps fall at specific points on the TRL scale.

BIRAC adapts the nine-level scale with separate definitions for areas including medical devices and diagnostics, and includes the regulatory approvals and quality certifications relevant to each stage. If you apply to BIRAC, use its device document. The map below is a practical guide to how levels usually line up, not an official definition. Our post on TRL levels explained covers the general scale.

The Indian regulatory frame, in brief

Under the Medical Devices Rules, 2017, devices are classed by risk:

  • Class A and B (low and low to moderate risk): manufacturing licences come from the State Licensing Authority.
  • Class C and D (moderate to high and high risk): manufacturing licences come from the Central Licensing Authority, that is, CDSCO.

Three steps matter most for readiness:

  1. Test licence. To manufacture a device for clinical investigation, testing, evaluation, demonstration or training, you apply on Form MD-12 and receive a licence on Form MD-13.
  2. Clinical investigation permission. To test an investigational device in people, you apply on Form MD-22 and receive permission on Form MD-23. The investigation follows an approved plan, pilot or pivotal.
  3. Manufacturing licence. For sale, you need a manufacturing licence from the right authority for your class. CDSCO notes that a facility making devices for use in clinical investigation must be compliant with a quality management system.

CDSCO's overview also says clinical investigation is not mandatory for Class A devices, and that some non-sterile, non-measuring Class A devices are exempt from licensing. All applications go through the online medical devices portal.

TRL 1 to 9 for a medical device

TRL for a medical device: what each level usually means

TRL 9Routine clinical use, post-market data
TRL 8Manufacturing licence, QMS in place
Safety and clinical data
TRL 7Clinical investigation in people
TRL 6Near-final prototype, safety tested
TRL 5Tested in simulated or animal use
TRL 4Lab prototype meets key requirements
TRL 3Principle proven on the bench
TRL 2Device concept and intended use defined
TRL 1Clinical need and scientific principle

TRL 1 to 3: need, concept and proof of principle

At TRL 1 you have a clinical need and a scientific principle that could address it. At TRL 2 you have a device concept, a draft intended use and a first view of the risk class. At TRL 3 you have shown on the bench that the principle works: a sensor detects the signal, a material degrades at the right rate, a mechanism delivers the force.

Evidence: literature, lab notebooks, bench data, a written intended use statement, a first risk class.

TRL 4: lab prototype against key requirements

You have a working prototype built in the lab and tested against the key functional requirements you wrote down. Accuracy, repeatability and basic durability are measured, not assumed.

Evidence: a requirements list, test protocols, results against each requirement, and a first risk analysis.

TRL 5: tested in a relevant environment

The prototype is tested in conditions close to clinical use: simulated use, phantoms, cadaver work or animal studies, depending on the device. Materials that touch the body are chosen with biological safety testing in mind.

Evidence: simulated-use or animal study reports, early biocompatibility plans or results, and an updated risk analysis.

TRL 6: near-final prototype, safety evidence in place

The design is close to final and made by a controlled process. Safety testing relevant to the device, such as biocompatibility and electrical safety, is done or well under way, and batches are made consistently. This is where you usually apply for a test licence (MD-12) to make units for testing and clinical investigation. CDSCO's overview notes that test batches must show compliance with the Essential Principles of Safety and Performance, with at least three batches to generate quality, stability and validation data.

Evidence: design documents, test reports, batch records, test licence application or licence.

TRL 7: clinical investigation

The device is tested in people under a CDSCO-permitted clinical investigation (MD-22 application, MD-23 permission) with ethics committee approval. A pilot study sits near the start of this level and a pivotal study near the end. For Class A devices, where clinical investigation is not mandatory, this level may rest on other performance evidence instead.

Evidence: approved plan, permissions, study reports.

TRL 8: licensed and manufacturable

The device has a manufacturing licence from the right authority for its class, is made under a quality management system and the design is frozen.

Evidence: licence, quality system records, validated manufacturing process.

TRL 9: in routine clinical use

The device is sold and used in routine care, and you collect post-market data on performance and complaints.

Evidence: sales and usage records, post-market surveillance reports.

Common mistakes

  • Calling a working bench prototype TRL 6. Without testing in conditions close to clinical use and without safety evidence, it is usually TRL 4.
  • Leaving biocompatibility to the end. A material change after animal or clinical work can send you back several levels.
  • Ignoring the risk class. The class decides the licensing authority and whether clinical investigation is needed. Settle it early, with expert input if unsure.
  • Building test units without a test licence. If you make units for clinical investigation, plan the MD-12 application in your timeline.
  • Using one framework's wording in another's form. BIRAC's device definitions and general TRL scales differ in detail. Use your funder's version. Our guide on how to prove your TRL shows how to build the evidence pack.

Checking where your device really stands

The jump from TRL 4 to TRL 6 is demanding, because safety testing and controlled manufacturing arrive at once. Our post on moving from TRL 4 to TRL 6 covers that stretch in more detail.

Before you write the TRL into a grant form, it helps to test your grading. TRL Pro gives you a structured TRL 1 to 9 assessment of your technology, using Zernyx's own copyrighted framework (ZTRAF) across more than 60 technology domains and subdomains, so you can see which level your evidence supports and what is still missing. You can run an assessment in TRL Pro.

Regulatory forms and requirements change. Check the current Medical Devices Rules and CDSCO guidance on cdsco.gov.in before you apply.

Common questions

What TRL is a medical device prototype that works on the bench?

Usually TRL 4 if it is a lab prototype tested against the key functional requirements. It moves to TRL 5 or 6 only when tested in conditions close to real use, such as simulated use, phantoms, cadavers or animal studies, with safety testing under way.

When do I need a CDSCO test licence?

When you manufacture a medical device in India for clinical investigation, testing, evaluation, demonstration or training. The application is on Form MD-12 and the licence is issued on Form MD-13, through the online medical devices portal.

Which TRL does a clinical investigation correspond to?

A device being tested in people under a CDSCO-permitted clinical investigation is commonly placed at TRL 7. Pilot studies may sit at the start of that level and pivotal studies at its end.

Does a Class A device need clinical investigation?

CDSCO's regulatory overview says clinical investigation is not mandatory for Class A devices, and some non-sterile, non-measuring Class A devices are exempt from licensing. Your TRL path can therefore be shorter, but you still need evidence of safety and performance.

Dr. Abhay Tharmatt
About the author

Dr. Abhay Tharmatt

Research Scientist, R&D, Zernyx Innovations

Connect on LinkedIn
More about Dr. Abhay Tharmatt
  • Ph.D. in Pharmaceutical Sciences, BITS Pilani.

Know your TRL before a reviewer asks.

Run a guided, evidence-backed TRL 1 to 9 assessment with TRL Pro, ready for funding, licensing and commercialization decisions.

Assess with TRL Pro

Keep reading

Looking for something else?